[
HOME
] [
INTRODUCTION
] [
LE VIRUS - H5N1
] [
PLAN NATIONAL
] [
NOUVELLES
] [
COMMENTAIRES
] [
WEB REFERENCES
] [
EPIDEMIE QUEBEC
] [
TRAITEMENT
] [
VIRUS
] [
ANTIVIRAUX
] [
PANDEMIC INFLUENZA
] [
E-MAIL
]
THERAPIE
CDC - Neuraminidase Inhibitors for Treatment of Influenza A and B Infections
The role of neuraminidase inhibitors in the treatment and prevention of influenza
Shahrour Naem
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
In our sample, postexposure prophylaxis with oseltamivir, 75 mg once daily for 7 days, protected close contacts of influenza-infected persons against influenza illness, prevented outbreaks within households, and was well tolerated.
Inhaled Drug Useful In Preventing Flu
ScienceDaily
Guidelines on neuraminidase inhibitors in children are not supported by evidence
Researchers Add New Drug Prophylactic Option Against Flu
Diana Olson, IDSA
Ventilator Management
Respiratory Hygiene/Cough Etiquette in Healthcare Settings
Copyright © 2005: Taxus Pharma / Construction des Trois-Monts Inc.